biospecimen_aliquot__bcr_aliquot_barcode	tcga-bh-a0bt-01a-11d-a12q-09
biospecimen_aliquot__bcr_aliquot_uuid	2299036e-7099-4b53-9143-5935442c3310
biospecimen_aliquot__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
biospecimen_aliquot__bcr_sample_barcode	tcga-bh-a0bt-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0108431810
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-02-22
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	3
biospecimen_aliquot__plate_id	a12q
biospecimen_aliquot__plate_row	h
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.93
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-bh-a0bt-01a-11d
biospecimen_analyte__bcr_analyte_uuid	06d901a7-8ca4-461a-9c36-ac1066f880d3
biospecimen_analyte__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
biospecimen_analyte__bcr_sample_barcode	tcga-bh-a0bt-01a
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-bh-a0bt
biospecimen_diagnostic_slides__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-bh-a0bt-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	9087b9e7-c0cd-4179-af57-ad9255785169
biospecimen_normal_control__bcr_patient_barcode	tcga-bh-a0bt
biospecimen_normal_control__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
biospecimen_normal_control__normal_tissue_anatomic_site	breast
biospecimen_portion__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
biospecimen_portion__bcr_portion_barcode	tcga-bh-a0bt-01a-11
biospecimen_portion__bcr_portion_uuid	3a23513c-4caf-4f85-9094-8cff3b58952e
biospecimen_portion__bcr_sample_barcode	tcga-bh-a0bt-01a
biospecimen_portion__date_of_creation	2010-06-09
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-bh-a0bt-01a-11d
biospecimen_protocol__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
biospecimen_protocol__bcr_sample_barcode	tcga-bh-a0bt-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
biospecimen_sample__bcr_sample_barcode	tcga-bh-a0bt-01a
biospecimen_sample__bcr_sample_uuid	7f7d8229-3daf-48be-bd16-ffe4314528b1
biospecimen_sample__days_to_collection	1167
biospecimen_sample__initial_weight	140
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-bh-a0bt.18e4043d-34bf-4cd1-9e2d-f906c7c7b019.pdf
biospecimen_sample__pathology_report_uuid	18e4043d-34bf-4cd1-9e2d-f906c7c7b019
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
biospecimen_shipment_portion__bcr_sample_barcode	tcga-bh-a0bt-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	99e5ad3c-e46a-4d06-9feb-33f1b3819e6f
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13c
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-bh-a0bt-01a-21-a13c-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
biospecimen_slide__bcr_sample_barcode	tcga-bh-a0bt-01a
biospecimen_slide__bcr_slide_barcode	tcga-bh-a0bt-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	0d7af972-fe18-47c7-b863-2bb47d611f22
biospecimen_slide__image_file_name	tcga-bh-a0bt-01a-01-tsa.0d7af972-fe18-47c7-b863-2bb47d611f22.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	2
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	20
biospecimen_slide__percent_tumor_cells	79
biospecimen_slide__percent_tumor_nuclei	70
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-bh-a0bt
biospecimen_tumor_sample__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
clinical_drug__bcr_drug_barcode	tcga-bh-a0bt-d59146
clinical_drug__bcr_drug_uuid	162f9144-80e7-4c0f-bf74-1d23dde80ef5
clinical_drug__bcr_patient_barcode	tcga-bh-a0bt
clinical_drug__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
clinical_drug__form_completion_date	2014-5-1
clinical_drug__pharmaceutical_therapy_drug_name	adriamycin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ended_days_to	139
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	97
clinical_drug__treatment_best_response	complete response
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-bh-a0bt-f59143
clinical_follow_up__bcr_followup_uuid	539edb85-18ff-4d9f-b1c5-f1c962551945
clinical_follow_up__bcr_patient_barcode	tcga-bh-a0bt
clinical_follow_up__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2014-5-1
clinical_follow_up__last_contact_days_to	2365
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	56
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1mi
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t1c
clinical_patient__anatomic_neoplasm_subdivision	right upper inner quadrant
clinical_patient__bcr_patient_barcode	tcga-bh-a0bt
clinical_patient__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
clinical_patient__birth_days_to	-20625
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__first_surgical_procedure_other	segmental mastectomy with sentinel lymph node excision and biopsy
clinical_patient__form_completion_date	2011-8-2
clinical_patient__gender	female
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2007
clinical_patient__last_contact_days_to	1386
clinical_patient__margin_status	negative
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__patient_id	a0bt
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	other
clinical_patient__tissue_source_site	bh
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-bh-a0bt
clinical_radiation__bcr_patient_uuid	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4
clinical_radiation__bcr_radiation_barcode	tcga-bh-a0bt-r59144
clinical_radiation__bcr_radiation_uuid	9c01b233-7499-4880-bdbf-74ae44ed26d6
clinical_radiation__form_completion_date	2014-5-1
clinical_radiation__radiation_adjuvant_fractions_total	36
clinical_radiation__radiation_adjuvant_units	gy
clinical_radiation__radiation_therapy_ended_days_to	227
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	167
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	66.4
clinical_radiation__treatment_best_response	complete response
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0BT-01A-11D-A12Q-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0BT-01A-11D-A12Q-09.bed.meta
manually_curated__id	tcga-bh-a0bt-01a-11d-a12q-09
manually_curated__md5sum	e50ae30cdf5fbab559cd09c278f31609
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	2299036e-7099-4b53-9143-5935442c3310
manually_curated__tumor_tag	brca
